Skip to main content

Published locations for Phase 3 trial of pixantrone leaves FDA uneasy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 3 trial of pixantrone leaves FDA uneasy

User login

  • Reset your password
  • /content/phase-3-trial-pixantrone-leaves-fda-uneasy
  • /hematology-oncology/article/186721/lymphoma-plasma-cell-disorders/phase-3-trial-pixantrone-leaves-fda-uneasy
  • /hematologytimes/article/186721/lymphoma-plasma-cell-disorders/phase-3-trial-pixantrone-leaves-fda